AV Nightmares: July 11th

When AV applications are implemented into a space well, they can blend in as if the room was designed around it. When done wrong, those rooms may never look the same again, if they are habitable at all. We highlighted some of the AV industries lowlights in this week’s AV nightmares.

If you have ever experienced a situation like this, first, we apologize. But make sure to tweet photos of it to @proavmkt to be featured in our next post!

 

We can boost your audio…no problem at all! We’re the pros.

https://twitter.com/UnifiedAV/status/896010933159555072

 

I don’t think this is what they meant when they said “7th inning stretch”

 

There isn’t a bad seat in the house!

 

 

Thankfully Mark had an Ipad handy

 

Apparently your 6th grade computer science teacher became a technician.

 

This might have been Mariah Carey’s mic pack (throwback joke)

 

Restart your system…just do it, already.

 

The installers might have had too much to drink on this one…

 

A chisel and hammer might have been used here

 

I have a sneaking suspicion that the fan was not turned on during this installation

 

And apparently this is more common than we thought….

 

If you stumble upon any AV Nightmares please submit them to us through the hashtag #msAVnightmares!

For the latest news, videos, and podcasts in the Professional AV Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @ProAVmkt
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More